142 related articles for article (PubMed ID: 20547460)
1. FDG PET/CT manifestations of hematopoietic malignancies of the breast.
Ginat DT; Puri S
Acad Radiol; 2010 Aug; 17(8):1026-30. PubMed ID: 20547460
[TBL] [Abstract][Full Text] [Related]
2. 18F-FDG PET/CT in myeloma with presumed solitary plasmocytoma of bone.
Nanni C; Rubello D; Zamagni E; Castellucci P; Ambrosini V; Montini G; Cavo M; Lodi F; Pettinato C; Grassetto G; Franchi R; Gross MD; Fanti S
In Vivo; 2008; 22(4):513-7. PubMed ID: 18712181
[TBL] [Abstract][Full Text] [Related]
3. Nonmammary malignancies of the breast: ultrasound, CT, and MRI.
Yang WT; Muttarak M; Ho LW
Semin Ultrasound CT MR; 2000 Oct; 21(5):375-94. PubMed ID: 11071618
[TBL] [Abstract][Full Text] [Related]
4. PET/CT and renal pathology: a blind spot for radiologists? Part 2--lymphoma, leukemia, and metastatic disease.
Zukotynski K; Lewis A; O'Regan K; Jacene H; Sakellis C; Almodovar S; Israel D
AJR Am J Roentgenol; 2012 Aug; 199(2):W168-74. PubMed ID: 22826418
[TBL] [Abstract][Full Text] [Related]
5. 18F-FDG PET/CT Demonstrated the Multiple Myeloma From Prostate.
Cheng A; Liping F; Wang X; Zhao L; Yang J
Clin Nucl Med; 2016 Apr; 41(4):328-30. PubMed ID: 26562573
[TBL] [Abstract][Full Text] [Related]
6. A case of duodenal involvement of multiple myeloma imaged by positron emission tomography with 18F-fluorodeoxyglucose.
Yasuda S; Hoshikawa T; Yazawa N; Fukumitsu H; Ishikawa K; Suzuki T; Sadahiro S; Shimakura Y; Shibuya M; Nasu S; Tajima T; Makuuchi H
Tokai J Exp Clin Med; 2001 Dec; 26(4-6):147-51. PubMed ID: 12030445
[TBL] [Abstract][Full Text] [Related]
7. Fluorodeoxyglucose positron emission tomography (FDG-PET) and PET/computed tomography imaging characteristics of thyroid lymphoma and their potential clinical utility.
Basu S; Li G; Bural G; Alavi A
Acta Radiol; 2009 Mar; 50(2):201-4. PubMed ID: 19089692
[TBL] [Abstract][Full Text] [Related]
8. PET/CT in benign and malignant musculoskeletal tumors and tumor-like conditions.
Choi YY; Kim JY; Yang SO
Semin Musculoskelet Radiol; 2014 Apr; 18(2):133-48. PubMed ID: 24715446
[TBL] [Abstract][Full Text] [Related]
9. F-18 FDG PET/CT in primary tonsillar lymphoma.
Zhang MJ; Jiang JJ; Jiang MS; He W
Clin Nucl Med; 2010 Sep; 35(9):710-2. PubMed ID: 20706049
[TBL] [Abstract][Full Text] [Related]
10. Interesting image. Assessment of plasmablastic lymphoma by F-18 FDG PET/CT: case report.
Cazaentre T; Sanhes L; Laurent G; Costa K; Vallantin X; Pascal-Ortiz D
Clin Nucl Med; 2010 Nov; 35(11):882-3. PubMed ID: 20940549
[No Abstract] [Full Text] [Related]
11. Clinical Application of
Zirakchian Zadeh M
Clin Lymphoma Myeloma Leuk; 2023 Nov; 23(11):800-814. PubMed ID: 37558532
[TBL] [Abstract][Full Text] [Related]
12. FDG PET/CT depicts cutaneous plasmocytoma.
Lapa C; Knop S; Lückerath K
Clin Nucl Med; 2014 Oct; 39(10):910-1. PubMed ID: 24873802
[TBL] [Abstract][Full Text] [Related]
13. PET Imaging for Hematologic Malignancies.
Hughes NM; Jacene HA
Radiol Clin North Am; 2021 Sep; 59(5):705-723. PubMed ID: 34392914
[TBL] [Abstract][Full Text] [Related]
14. Hematopoietic tumors and metastases involving bone.
Kim SH; Smith SE; Mulligan ME
Radiol Clin North Am; 2011 Nov; 49(6):1163-83, vi. PubMed ID: 22024293
[TBL] [Abstract][Full Text] [Related]
15. [18F-FDG PET-CT in a case of solitary plasmacytoma of the soft palate].
Fernández López R; Borrego Dorado I; Paz Coll A; Vázquez Albertino R; Gómez Camarero P; Sanz Viedma S
Rev Esp Med Nucl; 2010; 29(5):263-5. PubMed ID: 20663591
[TBL] [Abstract][Full Text] [Related]
16. The value of (18)F-fluorodeoxyglucose positron emission tomography/computed tomography for staging of primary extranodal head and neck lymphomas.
Schrepfer T; Haerle SK; Strobel K; Schaefer N; Hälg RA; Huber GF
Laryngoscope; 2010 May; 120(5):937-44. PubMed ID: 20422687
[TBL] [Abstract][Full Text] [Related]
17. Evolving Role of PET-Based Novel Quantitative Techniques in the Management of Hematological Malignancies.
Raynor WY; Zadeh MZ; Kothekar E; Yellanki DP; Alavi A
PET Clin; 2019 Jul; 14(3):331-340. PubMed ID: 31084773
[TBL] [Abstract][Full Text] [Related]
18. Whole-body (18)F-FDG PET identifies high-risk myeloma.
Durie BG; Waxman AD; D'Agnolo A; Williams CM
J Nucl Med; 2002 Nov; 43(11):1457-63. PubMed ID: 12411548
[TBL] [Abstract][Full Text] [Related]
19. FDG PET-CT in the management of primary breast lymphoma.
Santra A; Kumar R; Reddy R; Halanaik D; Kumar R; Bal CS; Malhotra A
Clin Nucl Med; 2009 Dec; 34(12):848-53. PubMed ID: 20139815
[TBL] [Abstract][Full Text] [Related]
20. Discordant findings of skeletal metastasis between tc 99M MDP bone scans and F18 FDG PET/CT imaging for advanced breast and lung cancers--two case reports and literature review.
Chen YW; Huang MY; Hsieh JS; Hou MF; Chou SH; Lin CL
Kaohsiung J Med Sci; 2007 Dec; 23(12):639-46. PubMed ID: 18192101
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
